“alirocumab” Archives

in
Entry Author Date Location
Amgen Bests Sanofi-Regeneron In PCSK9 Patent Case, Losers Vow Appeal 03/16/16 New York
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More 08/28/15 New York
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
Beer Out as Struggling Aegerion Shuffles Leadership Ranks 07/27/15 Boston
FDA OKs Cholesterol Fighter Praluent For More Patients Than Expected 07/24/15 New York
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors 07/07/15 Detroit Ann Arbor
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Rare Heart Disease Advocate: “I’m More Relieved Than I’ve Ever Been” 06/10/15 National
Advisors to FDA: Approve New Cholesterol Drug, But With Caveats 06/10/15 National
Take a Grain of Salt (Or Two) With New Cholesterol Drug Predictions 06/09/15 National
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
With Gilead’s $125M Purchase, FDA Voucher Program Gains Momentum 11/19/14 San Francisco
An Intriguing Program Takes on Tropical Diseases—But Not Ebola 09/10/14 National
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Regeneron, Sanofi Drug Holds Up in Eczema Study 07/09/14 New York
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More 10/18/13 Boston
Regeneron, Sanofi Pass First Key Test With Cholesterol-Lowering Drug 10/16/13 New York
Page 2 of 2 « previous page